The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Cutaneous Lupus Tied to Risk for Coexisting Autoimmune Conditions

Cutaneous Lupus Tied to Risk for Coexisting Autoimmune Conditions

May 10, 2018 • By Marilynn Larkin

  • Tweet
  • Email
Print-Friendly Version / Save PDF

NEW YORK (Reuters Health)—Patients with cutaneous lupus erythematosus (CLE) should be monitored closely for other autoimmune conditions, researchers suggest.

You Might Also Like
  • Remission of Rheumatoid Arthritis Tied to Lower Risk of Metabolic Syndrome
  • Autoimmune Diseases Common in Patients with Vitiligo
  • Some Jobs Tied to Higher Risk of RA
Also By This Author
  • After COVID-19-Associated MIS-C, Immune Changes Resolve

Dr. Benjamin Chong, Dr. Linda Hynan and Elaine Kunzler of the University of Texas Southwestern Medical Center in Dallas analyzed data from 129 adults in the UTSW Cutaneous Lupus Registry (mean age, 49; 79% women). Individuals who met at least four American College of Rheumatology (ACR) diagnostic criteria for systemic lupus erythematosus (SLE) were excluded.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

For the cross-sectional pilot study, autoimmune diagnoses were collected by patient history and a medical record review. During the six months following the initial study visit, participants were evaluated by specialists to confirm the diagnoses of concomitant autoimmune diseases.

As reported online May 2 in JAMA Dermatology, 23 participants (17.8%) were found to have coexisting autoimmune conditions. Thyroid disease (including Graves disease and Hashimoto thyroiditis) had the highest frequency at 4.7% (6 patients), followed by Sjogren syndrome (4 patients), rheumatoid arthritis (3), alopecia areata (3), and morphea (2).

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

One patient had rheumatoid arthritis, Sjogren syndrome and microscopic polyangiitis, and another had Sjogren syndrome and Guillain-Barre syndrome. Other conditions included immune thrombocytopenic purpura, microscopic polyangiitis, multiple sclerosis, pernicious anemia, and ulcerative colitis.

Coexisting autoimmune conditions were significantly more likely in patients with CLE who were white (odds ratio, 2.88), never smokers (OR, 3.28), had a family history of autoimmune disease (OR, 3.54), or a history of positive antinuclear antibody test result (OR, 4.87).

“We recommend that dermatologists treating patients with CLE maintain a low index of suspicion for presence of additional autoimmune conditions,” Kunzler (who will graduate from medical school this month) and Dr. Chong said in a joint email to Reuters Health.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“This can be done by inquiring about symptoms that are found in autoimmune conditions, especially those associated with autoimmune thyroid disease and inflammatory arthritis,” they explain. “Findings during clinical encounters that raise suspicion for autoimmune diseases should prompt dermatologists to have a low threshold to not only workup patients for coexisting autoimmune conditions, but also to communicate with and refer to appropriate specialists.”

“CLE is a complex disorder and care should be taken to minimize the disease burden and provide early identification of comorbidities,” they conclude.

Dr. Anca Askanase, Director, Columbia University Lupus Center in New York City, told Reuters Health that the study “further substantiates that CLE is part of the spectrum of autoantibody- mediated immune diseases.”

“It would indeed be interesting to know how many of the patients in this paper will ultimately develop SLE, since many of them meet several ACR criteria,” she said by email. “Additionally, (we don’t know whether) the Systemic Lupus International Collaborating Clinics criteria (were) evaluated for these patients.”

“As expected, a family history of autoimmune diseases and a positive anti-nuclear antibody test increased the likelihood of having an autoimmune disease,” she noted. “The association with white race and never smoker is somewhat unexpected.”

“The message of the paper is that a thorough review of systems and referral for appropriate testing is warranted,” Dr. Askanase said. “I would advocate that these patients should all see a rheumatologist.”

Reference

  1. Kunzler E, Hynan L, Chong B. Autoimmune Diseases in Patients With Cutaneous Lupus Erythematosus. JAMA Dermatology. 2018 May 2. https://jamanetwork.com/journals/jamadermatology/article-abstract/2679045?redirect=true

Filed Under: Conditions Tagged With: coexisting autoimmune conditions, cutaneous lupus erythematosus (CLE), UTSW Cutaneous Lupus Registry

You Might Also Like:
  • Remission of Rheumatoid Arthritis Tied to Lower Risk of Metabolic Syndrome
  • Autoimmune Diseases Common in Patients with Vitiligo
  • Some Jobs Tied to Higher Risk of RA
  • Herpes Zoster & the Risk of Stroke in Patients with Autoimmune Diseases

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)